{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T17:20:04Z","timestamp":1788888004953,"version":"build-2803163510"},"reference-count":150,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.ejmech.2022.114173","type":"journal-article","created":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T11:04:42Z","timestamp":1643972682000},"page":"114173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Quinoline heterocyclic containing plant and marine candidates against drug-resistant Mycobacterium tuberculosis: A systematic drug-ability investigation"],"prefix":"10.1016","volume":"232","author":[{"given":"Shasank S.","family":"Swain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanghamitra","family":"Pati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahziba","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2022.114173_bib1","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1080\/22221751.2020.1785334","article-title":"Molecular mechanisms of underlying genetic factors and associated mutations for drug resistance in Mycobacterium tuberculosis","volume":"9","author":"Swain","year":"2020","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.ejmech.2022.114173_bib2","unstructured":"reportGlobal Tuberculosis Report 2020. Geneva: WHO-2020. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/336069\/9789240013131-eng.pdf. (Assessed on 12 Sep. 2021)."},{"key":"10.1016\/j.ejmech.2022.114173_bib3","first-page":"S1201","article-title":"Global tuberculosis report 2020-Reflections on the global TB burden, treatment and prevention efforts","author":"Chakaya","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.ejmech.2022.114173_bib5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4103\/0971-5916.193278","article-title":"Undernutrition & tuberculosis in India: situation analysis & the way forward","volume":"144","author":"Padmapriyadarsini","year":"2016","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.ejmech.2022.114173_bib6","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12890-019-0953-0","article-title":"Nutritional status of tuberculosis patients, a comparative cross-sectional study","volume":"19","author":"Feleke","year":"2019","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.ejmech.2022.114173_bib7","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.19082\/3005","article-title":"Hematological and liver toxicity of anti-tuberculosis drugs","volume":"8","author":"Mirlohi","year":"2016","journal-title":"Electron. Physician"},{"key":"10.1016\/j.ejmech.2022.114173_bib8","article-title":"New antituberculous drugs derived from natural products: current perspectives and issues in antituberculous drug development","author":"Igarashi","year":"2017","journal-title":"J.\u00a0Antibiot. (Tokyo)"},{"key":"10.1016\/j.ejmech.2022.114173_bib9","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.biopha.2017.04.030","article-title":"Antibacterial, antifungal and antimycobacterial compounds from cyanobacteria","volume":"90","author":"Swain","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2022.114173_bib10","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ijid.2016.12.024","article-title":"New tuberculosis drug leads from naturally occurring compounds","volume":"56","author":"Quan","year":"2017","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.ejmech.2022.114173_bib11","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.3390\/molecules25133011","article-title":"The war against tuberculosis: a review of natural compounds and their derivatives","volume":"25","author":"Maiolini","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2022.114173_bib12","doi-asserted-by":"crossref","DOI":"10.2174\/1568026621666210705170510","article-title":"Drug-lead anti-tuberculosis phytochemicals: a systematic review","author":"Swain","year":"2021","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114173_bib13","doi-asserted-by":"crossref","first-page":"113732","DOI":"10.1016\/j.ejmech.2021.113732","article-title":"Natural products against key Mycobacterium tuberculosis enzymatic targets: emerging opportunities for drug discovery","volume":"224","author":"Cazzaniga","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114173_bib14","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/17460441.2016.1272757","article-title":"The structural modification of natural products for novel drug discovery","volume":"12","author":"Yao","year":"2017","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2022.114173_bib15","doi-asserted-by":"crossref","first-page":"586294","DOI":"10.3389\/fchem.2020.586294","article-title":"Handling the hurdles on the way to anti-tuberculosis drug development","volume":"8","author":"Dalberto","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejmech.2022.114173_bib16","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","article-title":"Natural products in drug discovery: advances and opportunities","volume":"20","author":"Atanasov","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2022.114173_bib17","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1017\/S0031182016001876","article-title":"Fragment-based approaches to TB drugs","volume":"145","author":"Marchetti","year":"2018","journal-title":"Parasitology"},{"key":"10.1016\/j.ejmech.2022.114173_bib18","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1055\/s-1999-13988","article-title":"Activity against Mycobacterium tuberculosis of alkaloid constituents of angostura bark, Galipea officinalis","volume":"65","author":"Houghton","year":"1999","journal-title":"Planta Med."},{"key":"10.1016\/j.ejmech.2022.114173_bib19","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1021\/np9701889","article-title":"Antitubercular natural products: berberine from the roots of commercial hydrastis canadensis powder. Isolation of inactive 8-oxotetrahydrothalifendine, canadine, beta-hydrastine, and two new quinic acid esters, hycandinic acid esters-1 and -2","volume":"61","author":"Gentry","year":"1998","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2022.114173_bib20","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1021\/np070293a","article-title":"Bioactive constituents of the roots of Polyalthia cerasoides","volume":"70","author":"Kanokmedhakul","year":"2007","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2022.114173_bib21","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0944-7113(98)80030-5","article-title":"Antibacterial and antifungal activities of neocryptolepine, biscryptolepine and cryptoquindoline, alkaloids isolated from Cryptolepis sanguinolenta","volume":"5","author":"Cimanga","year":"1998","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejmech.2022.114173_bib22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.fitote.2009.01.002","article-title":"Alkaloids as potential anti-tubercular agents","volume":"80","author":"Kishore","year":"2009","journal-title":"Fitoterapia"},{"key":"10.1016\/j.ejmech.2022.114173_bib23","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1021\/np0401260","article-title":"Antimycobacterial compounds from Piper sanctum","volume":"67","author":"Mata","year":"2004","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2022.114173_bib24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0378-8741(01)00350-6","article-title":"The evaluation of forty-three plant species for in\u00a0vitro antimycobacterial activities; isolation of active constituents from Psoralea corylifolia and Sanguinaria canadensis","volume":"79","author":"Newton","year":"2002","journal-title":"J.\u00a0Ethnopharmacol."},{"key":"10.1016\/j.ejmech.2022.114173_bib25","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/1098-1128(200101)21:1<61::AID-MED2>3.0.CO;2-F","article-title":"Benzo[c]phenanthridine bases and their antituberculosis activity","volume":"21","author":"Ishikawa","year":"2001","journal-title":"Med. Res. Rev."},{"issue":"24","key":"10.1016\/j.ejmech.2022.114173_bib26","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0031-9422(00)80760-8","article-title":"Sesquiterpenes and alkaloids from Cleistopholis patens","author":"Waterman","year":"1985","journal-title":"Phytochemistry"},{"key":"10.1016\/j.ejmech.2022.114173_bib27","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/ptr.1284","article-title":"Cryptolepine hydrochloride: a potent antimycobacterial alkaloid derived from Cryptolepis sanguinolenta","volume":"17","author":"Gibbons","year":"2003","journal-title":"Phytother Res."},{"key":"10.1016\/j.ejmech.2022.114173_bib28","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jep.2013.01.013","article-title":"Zanthoxylum capense constituents with antimycobacterial activity against Mycobacterium tuberculosis in\u00a0vitro and ex\u00a0vivo within human macrophages","volume":"146","author":"Luo","year":"2013","journal-title":"J.\u00a0Ethnopharmacol."},{"key":"10.1016\/j.ejmech.2022.114173_bib29","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.phymed.2016.02.017","article-title":"In\u00a0vitro activity of (-)-deoxypergularinine, on its own and in combination with anti-tubercular drugs, against resistant strains of Mycobacterium tuberculosis","volume":"23","author":"Nam","year":"2016","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejmech.2022.114173_bib30","first-page":"71","article-title":"Evaluation of some plant-derived secondary metabolites against sensitive and multidrug resistant","volume":"53","author":"Camacho-Corona","year":"2009","journal-title":"Mycobacterium tuberculosis, J. Mex Chem. Soc."},{"key":"10.1016\/j.ejmech.2022.114173_bib31","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1021\/np700719e","article-title":"Constituents of the root wood of Zanthoxylum wutaiense with antitubercular activity","volume":"71","author":"Huang","year":"2008","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2022.114173_bib32","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/jam.12753","article-title":"Antagonistic effects of indolo- quinazoline alkaloids on antimycobacterial activity of evocarpine","volume":"118","author":"Hochfellner","year":"2015","journal-title":"J.\u00a0Appl. Microbiol."},{"key":"10.1016\/j.ejmech.2022.114173_bib33","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1016\/j.ejmech.2011.04.025","article-title":"Mycobacterium tuberculosis and cholinesterase inhibitors from Voacanga globosa","volume":"46","author":"Macabeo","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114173_bib34","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ijantimicag.2007.02.004","article-title":"Quinoline alkaloids from Lunasia amara inhibit Mycobacterium tuberculosis H37Rv in\u00a0vitro","volume":"29","author":"Aguinaldo","year":"2007","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2022.114173_bib35","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1080\/13880200600714111","article-title":"Biological activities of alkaloids from","volume":"44","author":"Wirasathien","year":"2006","journal-title":"Pseuduvaria setose. Pharm. Biol."},{"key":"10.1016\/j.ejmech.2022.114173_bib36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jep.2009.06.023","article-title":"Bioactive styryllactones and alkaloid from flowers of Goniothalamus laoticus","volume":"125","author":"Lekphrom","year":"2009","journal-title":"J.\u00a0Ethnopharmacol."},{"key":"10.1016\/j.ejmech.2022.114173_bib37","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1021\/jm00100a012","article-title":"Copyrine alkaloids: synthesis, spectroscopic characterization, and antimycotic\/antimycobacterial activity of A- and B-ring-functionalized sampangines","volume":"35","author":"Peterson","year":"1992","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114173_bib38","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ejmech.2017.06.005","article-title":"Drug development against tuberculosis: impact of alkaloids","volume":"137","author":"Mishra","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114173_bib39","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.phytochem.2016.02.005","article-title":"Tetrandrine-A molecule of wide bioactivity","volume":"125","author":"Bhagya","year":"2016","journal-title":"Phytochemistry"},{"key":"10.1016\/j.ejmech.2022.114173_bib40","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1016\/j.bmcl.2012.02.053","article-title":"Antimycobacterial activity of bisbenzylisoquinoline alkaloids from Tiliacora triandra against multidrug-resistant isolates of Mycobacterium tuberculosis","volume":"22","author":"Sureram","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2022.114173_bib41","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1093\/jac\/dkq313","article-title":"Anti-tubercular screening of natural products from Colombian plants: 3-methoxynordomesticine, an inhibitor of MurE ligase of Mycobacterium tuberculosis","volume":"65","author":"Guzman","year":"2010","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2022.114173_bib42","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1016\/j.tet.2010.05.033","article-title":"Anti-tuberculosis natural products, synthesis and biological evaluation of pyridoacridone alkaloids related to ascididemin","volume":"66","author":"Appleton","year":"2010","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2022.114173_bib43","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1021\/np010485k","article-title":"Ecteinascidins 770 and 786 from the Thai tunicate Ecteinascidia thurstoni","volume":"65","author":"Suwanborirux","year":"2002","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2022.114173_bib44","doi-asserted-by":"crossref","first-page":"7397","DOI":"10.1016\/S0040-4020(02)00825-6","article-title":"12,34-oxamanzamines, novel biocatalytic and natural products from manzamine producing Indo-Pacific sponges","volume":"58","author":"Yousaf","year":"2002","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2022.114173_bib45","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1021\/np0400095","article-title":"Three new manzamine alkaloids from a common Indonesian sponge and their activity against infectious and tropical parasitic diseases","volume":"67","author":"Rao","year":"2004","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2022.114173_bib46","doi-asserted-by":"crossref","first-page":"4426","DOI":"10.1021\/jo00301a040","article-title":"Kuanoniamines A, B, C, and D: pentacyclic alkaloids from a tunicate and its prosobranch mollusk predator Chelynotus semperi","volume":"55","author":"Carroll","year":"1990","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2022.114173_bib47","doi-asserted-by":"crossref","first-page":"13382","DOI":"10.1021\/ja030087z","article-title":"Manadomanzamines A and B: a novel alkaloid ring system with potent activity against mycobacteria and HIV-1","volume":"125","author":"Peng","year":"2003","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2022.114173_bib48","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1021\/np0601399","article-title":"Manzamine B and E and ircinal A related alkaloids from an Indonesian Acanthostrongylophora sponge and their activity against infectious, tropical parasitic, and Alzheimer's diseases","volume":"69","author":"Rao","year":"2006","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2022.114173_bib49","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1021\/jm030475b","article-title":"New manzamine alkaloids from an Indo-Pacific sponge. Pharmacokinetics, oral availability, and the significant activity of several manzamines against HIV-I, AIDS opportunistic infections, and inflammatory diseases","volume":"47","author":"Yousaf","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114173_bib50","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1021\/np900751k","article-title":"Structures and antimicrobial activities of pyridoacridine alkaloids isolated from different chromotypes of the ascidian Cystodytes dellechiajei","volume":"73","author":"Bontemps","year":"2010","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2022.114173_bib51","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.38200","article-title":"Compensatory evolution drives multidrug-resistant tuberculosis in Central Asia","volume":"7","author":"Merker","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.ejmech.2022.114173_bib52","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13073-020-00726-5","article-title":"Phylogenetically informative mutations in genes implicated in antibiotic resistance in Mycobacterium tuberculosis complex","volume":"12","author":"Merker","year":"2020","journal-title":"Genome Med."},{"key":"10.1016\/j.ejmech.2022.114173_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0253826","article-title":"Genotypic diversity of multi- and pre-extremely drug-resistant Mycobacterium tuberculosis isolates from Morocco","volume":"16","author":"Oudghiri","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2022.114173_bib54","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/femsre\/fux011","article-title":"Antimicrobial resistance in Mycobacterium tuberculosis: mechanistic and evolutionary perspectives","volume":"41","author":"Gygli","year":"2017","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2022.114173_bib55","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3390\/molecules23040795","article-title":"Antibiotic use in agriculture and its consequential resistance in environmental sources: potential public health implications","volume":"23","author":"Manyi-Loh","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2022.114173_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008357","article-title":"Insertion and deletion evolution reflects antibiotics selection pressure in a Mycobacterium tuberculosis outbreak","volume":"16","author":"Godfroid","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2022.114173_bib57","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1186\/s12889-021-10267-0","article-title":"Socio-economic drivers of drug-resistant tuberculosis in Africa: a scoping review","volume":"21","author":"Cannon","year":"2021","journal-title":"BMC Publ. Health"},{"key":"10.1016\/j.ejmech.2022.114173_bib58","doi-asserted-by":"crossref","first-page":"12887","DOI":"10.1073\/pnas.1717160115","article-title":"Technologies to address antimicrobial resistance","volume":"115","author":"Baker","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2022.114173_bib59","first-page":"1","article-title":"Towards the sustainable discovery and development of new antibiotics","author":"Miethke","year":"2021","journal-title":"Nat. Rev. Chem."},{"key":"10.1016\/j.ejmech.2022.114173_bib60","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3390\/antibiotics10080981","article-title":"Pharmaceutical approaches on antimicrobial resistance: prospects and challenges","volume":"10","author":"Nainu","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ejmech.2022.114173_bib61","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1111\/jam.14478","article-title":"Recent updates on drug resistance in Mycobacterium tuberculosis","volume":"128","author":"Singh","year":"2020","journal-title":"J.\u00a0Appl. Microbiol."},{"key":"10.1016\/j.ejmech.2022.114173_bib62","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3389\/fmicb.2017.00681","article-title":"New insights in to the intrinsic and acquired drug resistance mechanisms in Mycobacteria","volume":"8","author":"Nasiri","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmech.2022.114173_bib63","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fcimb.2018.00114","article-title":"Molecular targets related drug resistance mechanisms in MDR-, XDR-, and TDR-Mycobacterium tuberculosis strains","volume":"8","author":"Hameed","year":"2018","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.ejmech.2022.114173_bib64","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1073\/pnas.1721545115","article-title":"Plasticity of Mycobacterium tuberculosis NADH dehydrogenases and their role in virulence","volume":"115","author":"Vilch\u00e8ze","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2022.114173_bib65","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/gbe\/evr066","article-title":"The lower bound to the evolution of mutation rates","volume":"3","author":"Lynch","year":"2011","journal-title":"Genome Biol Evol"},{"key":"10.1016\/j.ejmech.2022.114173_bib66","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MGM2-0014-2013","article-title":"Resistance to isoniazid and ethionamide in mycobacterium tuberculosis: genes, mutations, and causalities","volume":"2","author":"Vilch\u00e8ze","year":"2014","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.ejmech.2022.114173_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119628","article-title":"Genetic mutations associated with isoniazid resistance in Mycobacterium tuberculosis: a systematic review","volume":"10","author":"Seifert","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2022.114173_bib68","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1093\/jac\/dkv054","article-title":"Bactericidal mode of action of bedaquiline","volume":"70","author":"Hards","year":"2015","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2022.114173_bib69","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/jac\/dkw426","article-title":"Mechanisms of action and therapeutic efficacies of the lipophilic antimycobacterial agents clofazimine and bedaquiline","volume":"72","author":"Cholo","year":"2017","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2022.114173_bib70","doi-asserted-by":"crossref","first-page":"19646","DOI":"10.1073\/pnas.1907946116","article-title":"Mode-of-action profiling reveals glutamine synthetase as a collateral metabolic vulnerability of M.\u00a0tuberculosis to bedaquiline","volume":"116","author":"Wang","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2022.114173_bib71","doi-asserted-by":"crossref","first-page":"a025320","DOI":"10.1101\/cshperspect.a025320","article-title":"Topoisomerase inhibitors: fluoroquinolone mechanisms of action and resistance","volume":"6","author":"Hooper","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.ejmech.2022.114173_bib72","doi-asserted-by":"crossref","first-page":"5662","DOI":"10.3390\/molecules25235662","article-title":"Quinolones: mechanism, lethality and their contributions to antibiotic resistance","volume":"25","author":"Bush","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2022.114173_bib73","doi-asserted-by":"crossref","first-page":"e02418","DOI":"10.1128\/AAC.02418-20","article-title":"Comparative efficacy of the novel diarylquinoline TBAJ-587 and bedaquiline against a resistant Rv0678 mutant in a mouse model of tuberculosis","volume":"65","author":"Xu","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2022.114173_bib74","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1128\/AAC.00417-10","article-title":"Characteristic resistance mechanism of Mycobacterium tuberculosis to DC-159a, a new respiratory quinolone","volume":"55","author":"Sekiguchi","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2022.114173_bib75","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1128\/AAC.02358-15","article-title":"Compensatory mutations of rifampin resistance are associated with transmission of multidrug-resistant Mycobacterium tuberculosis Beijing genotype strains in China","volume":"60","author":"Li","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2022.114173_bib76","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2147\/IDR.S230774","article-title":"Detection of novel gene mutations associated with pyrazinamide resistance in multidrug-resistant Mycobacterium tuberculosis clinical isolates in Southern China","volume":"13","author":"Hameed","year":"2020","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.ejmech.2022.114173_bib77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100078","article-title":"Screening for streptomycin resistance-conferring mutations in Mycobacterium tuberculosis clinical isolates from Poland","volume":"9","author":"Jagielski","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2022.114173_bib78","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1021\/bi5000564","article-title":"Mechanism of quinolone action and resistance","volume":"53","author":"Aldred","year":"2014","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.ejmech.2022.114173_bib79","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3390\/antibiotics8040261","article-title":"Re-understanding the mechanisms of action of the anti-mycobacterial drug bedaquiline","volume":"8","author":"Sarathy","year":"2019","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ejmech.2022.114173_bib80","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s12879-021-06024-8","article-title":"Molecular characterization of multidrug-resistant tuberculosis against levofloxacin, moxifloxacin, bedaquiline, linezolid, clofazimine, and delamanid in southwest of China","volume":"21","author":"Zheng","year":"2021","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.ejmech.2022.114173_bib81","doi-asserted-by":"crossref","first-page":"947","DOI":"10.4155\/fmc.15.34","article-title":"Recent advances in research of natural and synthetic bioactive quinolines","volume":"7","author":"Chung","year":"2015","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114173_bib82","doi-asserted-by":"crossref","first-page":"103291","DOI":"10.1016\/j.bioorg.2019.103291","article-title":"Recent advances in the synthetic and medicinal perspective of quinolones: a review","volume":"92","author":"Dhiman","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2022.114173_bib83","doi-asserted-by":"crossref","first-page":"104639","DOI":"10.1016\/j.bioorg.2021.104639","article-title":"Quinolines, a perpetual, multipurpose scaffold in medicinal chemistry","volume":"109","author":"Yadav","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2022.114173_bib84","doi-asserted-by":"crossref","first-page":"986","DOI":"10.3390\/molecules21080986","article-title":"Recent advances in metal-free quinoline synthesis","volume":"21","author":"Ramann","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2022.114173_bib85","doi-asserted-by":"crossref","first-page":"5093","DOI":"10.1038\/s41598-017-04108-7","article-title":"A\u00a0novel protein kinase inhibitor IMB-YH-8 with anti-tuberculosis activity","volume":"7","author":"Xu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2022.114173_bib86","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.tube.2018.04.002","article-title":"Identification of TB-E12 as a novel FtsZ inhibitor with anti-tuberculosis activity","volume":"110","author":"Lin","year":"2018","journal-title":"Tuberculosis"},{"key":"10.1016\/j.ejmech.2022.114173_bib87","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ejmech.2017.11.087","article-title":"Naturally occurring Diels-Alder-type adducts from Morus nigra as potent inhibitors of Mycobacterium tuberculosis protein tyrosine phosphatase B","volume":"144","author":"Mascarello","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114173_bib88","doi-asserted-by":"crossref","first-page":"113568","DOI":"10.1016\/j.ejmech.2021.113568","article-title":"The mur enzymes chink in the armour of Mycobacterium tuberculosis cell wall","volume":"222","author":"Shinde","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114173_bib89","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1039\/D1NP00011J","article-title":"Anti-mycobacterial natural products and mechanisms of action","volume":"39","author":"Han","year":"2022","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.ejmech.2022.114173_bib90","doi-asserted-by":"crossref","first-page":"40800","DOI":"10.18632\/oncotarget.8315","article-title":"Tetrandrine, a Chinese plant-derived alkaloid, is a potential candidate for cancer chemotherapy","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2022.114173_bib91","doi-asserted-by":"crossref","first-page":"594852","DOI":"10.3389\/fphar.2020.594852","article-title":"Pharmacokinetics and excretion of berberine and its nine metabolites in rats","volume":"11","author":"Feng","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2022.114173_bib92","first-page":"8823764","article-title":"Antimycobacterial and PknB inhibitory activities of Venezuelan medicinal plants","volume":"2020","author":"Aranaga","year":"2020","journal-title":"Internet J. Microbiol."},{"key":"10.1016\/j.ejmech.2022.114173_bib93","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0228657","article-title":"Mycobacterium tuberculosis thymidylate synthase (ThyX) is a target for plumbagin, a natural product with antimycobacterial activity","volume":"15","author":"Sarkar","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2022.114173_bib94","first-page":"1646","article-title":"Antifolate activity of plant polyphenols against","volume":"29","author":"Raju","year":"2015","journal-title":"Mycobacterium tuberculosis. Phytother Res."},{"key":"10.1016\/j.ejmech.2022.114173_bib95","first-page":"1","article-title":"Computational approach for locating effective cyanobacterial compounds against","volume":"51","author":"Swain","year":"2017","journal-title":"Mycobacterium tuberculosis. Indian J. Pharma Educ. Res."},{"key":"10.1016\/j.ejmech.2022.114173_bib96","doi-asserted-by":"crossref","first-page":"12238","DOI":"10.1038\/s41598-018-30209-y","article-title":"Investigation of the anti-TB potential of selected propolis constituents using a molecular docking approach","volume":"8","author":"Ali","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2022.114173_bib97","doi-asserted-by":"crossref","first-page":"107205","DOI":"10.1016\/j.compbiolchem.2020.107205","article-title":"Structure-based discovery of novel inhibitors of Mycobacterium tuberculosis CYP121 from Indonesian natural products","volume":"85","author":"Prasasty","year":"2020","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.ejmech.2022.114173_bib98","first-page":"1","article-title":"Antituberculosis, antioxidant and cytotoxicity profiles of quercetin: a systematic and cost-effective in silico and in\u00a0vitro approach","author":"Swain","year":"2021","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.ejmech.2022.114173_bib99","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.2147\/DDDT.S97043","article-title":"Toward antituberculosis drugs: in silico screening of synthetic compounds against Mycobacterium tuberculosis l,d-transpeptidase 2","volume":"10","author":"Billones","year":"2016","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejmech.2022.114173_bib100","doi-asserted-by":"crossref","first-page":"103610","DOI":"10.1016\/j.bioorg.2020.103610","article-title":"Novel pyrazine based anti-tubercular agents: design, synthesis, biological evaluation and in silico studies","volume":"96","author":"Hassan","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2022.114173_bib101","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/j.ejmech.2009.12.074","article-title":"Structure-activity relationship of new anti-tuberculosis agents derived from oxazoline and oxazole benzyl esters","volume":"45","author":"Moraski","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114173_bib102","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/978-1-62703-342-8_6","article-title":"On exploring structure-activity relationships","volume":"993","author":"Guha","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejmech.2022.114173_bib103","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.4155\/fmc-2018-0281","article-title":"Structure-activity relationship of natural and synthetic coumarin derivatives against Mycobacterium tuberculosis","volume":"12","author":"Pires","year":"2020","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114173_bib104","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/ardp.201200249","article-title":"Synthesis and selective inhibitory activity against human COX-1 of novel 1-(4-substituted-thiazol-2-yl)-3,5-di(hetero)aryl-pyrazoline derivatives","volume":"345","author":"Carradori","year":"2012","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.ejmech.2022.114173_bib105","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jsps.2014.07.009","article-title":"Design, synthesis and antibacterial potential of 5-(benzo[d][1,3]dioxol-5-yl)-3-tert-butyl-1-substituted-4,5-dihydropyrazoles","volume":"23","author":"El-Behairy","year":"2015","journal-title":"Saudi Pharmaceut. J."},{"issue":"1","key":"10.1016\/j.ejmech.2022.114173_bib106","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jare.2014.11.002","article-title":"A\u00a0mini review on pyridoacridines: prospective lead compounds in medicinal chemistry","volume":"6","author":"Sharma","year":"2015","journal-title":"J.\u00a0Adv. Res."},{"key":"10.1016\/j.ejmech.2022.114173_bib107","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/md14020026","article-title":"New perspectives in the chemistry of marine pyridoacridine alkaloids","volume":"14","author":"Plodek","year":"2016","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2022.114173_bib108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13659-016-0115-5","article-title":"Natural products diversity of marine ascidians (tunicates; ascidiacea) and successful drugs in clinical development","volume":"7","author":"Palanisamy","year":"2017","journal-title":"Nat. Prod. Bioprospect"},{"key":"10.1016\/j.ejmech.2022.114173_bib109","doi-asserted-by":"crossref","first-page":"5043","DOI":"10.1002\/ejoc.201900401","article-title":"Pyridoacridines in the 21st century","author":"Joule","year":"2019","journal-title":"Eur. J. Org Chem."},{"key":"10.1016\/j.ejmech.2022.114173_bib110","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2174\/138161207780162818","article-title":"The manzamines as an example of the unique structural classes available for the discovery and optimization of infectious disease controls based on marine natural products","volume":"13","author":"Hamann","year":"2007","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejmech.2022.114173_bib111","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1038\/s41598-019-38590-y","article-title":"Macrophage migration inhibitory factor acts as the potential target of a newly synthesized compound, 1-(9'-methyl-3'-carbazole)-3, 4-dihydro-\u03b2-carboline","volume":"9","author":"Ko","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2022.114173_bib112","doi-asserted-by":"crossref","first-page":"17993","DOI":"10.1021\/acsomega.0c01256","article-title":"\u03b2-Carboline derivatives tackling malaria: biological evaluation and docking analysis","volume":"5","author":"Gorki","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2022.114173_bib113","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114173_bib114","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1021\/tx200211v","article-title":"Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety","volume":"24","author":"Meanwell","year":"2011","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ejmech.2022.114173_bib115","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1002\/cmdc.200700112","article-title":"Design, synthesis, and pharmacological evaluation of mefloquine-based ligands as novel antituberculosis agents","volume":"2","author":"Mao","year":"2007","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2022.114173_bib116","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3109\/14756366.2014.930454","article-title":"Quinoline and quinolones: promising scaffolds for future antimycobacterial agents","volume":"30","author":"Singh","year":"2015","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114173_bib117","first-page":"354","article-title":"A\u00a0review on quinoline hydrazone derivatives as a new class of potent antitubercular and anticancer agents","volume":"6","author":"Mandewale","year":"2017","journal-title":"Beni-Suef Univ J. Bas. Appl. Sci."},{"key":"10.1016\/j.ejmech.2022.114173_bib118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsps.2012.03.002","article-title":"Quinoline: a versatile heterocyclic","volume":"21","author":"Marella","year":"2013","journal-title":"Saudi Pharmaceut. J."},{"key":"10.1016\/j.ejmech.2022.114173_bib119","doi-asserted-by":"crossref","first-page":"626065","DOI":"10.3389\/fphar.2020.626065","article-title":"Novel hybrid chc from \u03b2-carboline and n-hydroxy acrylamide overcomes drug-resistant hepatocellular carcinoma by promoting apoptosis, dna damage, and cell cycle arrest","volume":"11","author":"Miao","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2022.114173_bib120","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1186\/1471-2202-9-S3-S7","article-title":"Requirements for a lead compound to become a clinical candidate","volume":"9","author":"Hefti","year":"2008","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.ejmech.2022.114173_bib121","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1476-5381.2010.01127.x","article-title":"Principles of early drug discovery","volume":"162","author":"Hughes","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2022.114173_bib122","doi-asserted-by":"crossref","first-page":"D1080","DOI":"10.1093\/nar\/gkv1192","article-title":"WITHDRAWN--a resource for withdrawn and discontinued drugs","volume":"44","author":"Siramshetty","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2022.114173_bib123","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.3390\/molecules25163619","article-title":"Naturally-occurring alkaloids of plant origin as potential antimicrobials against antibiotic-resistant infections","volume":"25","author":"Casciaro","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2022.114173_bib124","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.conctc.2018.08.001","article-title":"Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: a review","volume":"11","author":"Fogel","year":"2018","journal-title":"Contemp Clin Trials Commun"},{"key":"10.1016\/j.ejmech.2022.114173_bib125","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/cbdd.13685","article-title":"Isoniazid-phytochemical conjugation: a new approach for potent and less toxic anti-TB drug development","volume":"96","author":"Swain","year":"2020","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2022.114173_bib126","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/ddr.21746","article-title":"Phytochemical conjugation as a potential semisynthetic approach toward reactive and reuse of obsolete sulfonamides against pathogenic bacteria","volume":"82","author":"Swain","year":"2021","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ejmech.2022.114173_bib127","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1021\/ci5000467","article-title":"Silico prediction of chemical acute oral toxicity using multi-classification methods","volume":"54","author":"Li","year":"2014","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2022.114173_bib128","doi-asserted-by":"crossref","first-page":"e5646","DOI":"10.1590\/1414-431x20165646","article-title":"Non-clinical studies in the process of new drug development - Part II: good laboratory practice, metabolism, pharmacokinetics, safety and dose translation to clinical studies","volume":"49","author":"Andrade","year":"2016","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.ejmech.2022.114173_bib129","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fchem.2018.00030","article-title":"Silico prediction of chemical toxicity for drug design using machine learning methods and structural alerts","volume":"6","author":"Yang","year":"2018","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejmech.2022.114173_bib130","doi-asserted-by":"crossref","first-page":"W257","DOI":"10.1093\/nar\/gky318","article-title":"ProTox-II: a webserver for the prediction of toxicity of chemicals","volume":"46","author":"Banerjee","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2022.114173_bib131","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12951-018-0392-8","article-title":"Nano based drug delivery systems: recent developments and future prospects","volume":"16","author":"Patra","year":"2018","journal-title":"J.\u00a0Nanobiotechnol."},{"key":"10.1016\/j.ejmech.2022.114173_bib132","doi-asserted-by":"crossref","first-page":"7866","DOI":"10.1038\/s41598-019-44256-6","article-title":"Exploiting chitosan and gold nanoparticles for antimycobacterial activity of in silico identified antimicrobial motif of human neutrophil peptide-1","volume":"9","author":"Sharma","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2022.114173_bib133","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.2147\/IJN.S241183","article-title":"Silver nanoparticles for the therapy of tuberculosis","volume":"15","author":"T\u0103b\u0103ran","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejmech.2022.114173_bib134","doi-asserted-by":"crossref","first-page":"9325","DOI":"10.1038\/srep09325","article-title":"Clustered distribution of natural product leads of drugs in the chemical space as influenced by the privileged target-sites","volume":"5","author":"Tao","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2022.114173_bib135","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3389\/fgene.2019.00368","article-title":"Informatics and computational methods in natural product drug discovery: a review and perspectives","volume":"10","author":"Romano","year":"2019","journal-title":"Front. Genet."},{"key":"10.1016\/j.ejmech.2022.114173_bib136","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3390\/biom11040546","article-title":"Cluster Analysis of medicinal plants and targets based on multipartite network","volume":"11","author":"Lee","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejmech.2022.114173_bib137","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2022.114173_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.tet.2020.131801","article-title":"Chemical derivatization of natural products: semisynthesis and pharmacological aspects-A decade update","volume":"78","author":"Majhi","year":"2021","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2022.114173_bib139","doi-asserted-by":"crossref","first-page":"4797","DOI":"10.3390\/molecules25204797","article-title":"Chemistry and biological activity of alkaloids from the genus Lycoris (Amaryllidaceae)","volume":"25","author":"Cahl\u00edkov\u00e1","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2022.114173_bib140","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.3390\/molecules25163619","article-title":"Naturally-occurring alkaloids of plant origin as potential antimicrobials against antibiotic-resistant infections","volume":"25","author":"Casciaro","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2022.114173_bib141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsps.2012.03.002","article-title":"Quinoline: a versatile heterocyclic","volume":"21","author":"Marella","year":"2013","journal-title":"Saudi Pharmaceut. J."},{"key":"10.1016\/j.ejmech.2022.114173_bib142","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.biopha.2014.10.007","article-title":"Quinoline: a promising antitubercular target","volume":"68","author":"Keri","year":"2014","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2022.114173_bib143","first-page":"354","article-title":"A\u00a0review on quinoline hydrazone derivatives as a new class of potent antitubercular and anticancer agents","volume":"6","author":"Mandewale","year":"2017","journal-title":"Beni-Suef Uni. J. Basic Appl. Sci."},{"key":"10.1016\/j.ejmech.2022.114173_bib144","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3390\/pathogens7040088","article-title":"Modelling a silent epidemic: a review of the in\u00a0vitro models of latent tuberculosis","volume":"7","author":"Gibson","year":"2018","journal-title":"Pathogens"},{"key":"10.1016\/j.ejmech.2022.114173_bib145","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1080\/17460441.2020.1707801","article-title":"In\u00a0vitro drug discovery models for Mycobacterium tuberculosis relevant for host infection","volume":"15","author":"Parish","year":"2020","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2022.114173_bib146","doi-asserted-by":"crossref","first-page":"656419","DOI":"10.3389\/fimmu.2021.656419","article-title":"Evaluation of berberine as an adjunct to TB treatment","volume":"12","author":"Ozturk","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2022.114173_bib147","doi-asserted-by":"crossref","first-page":"658637","DOI":"10.3389\/fmicb.2021.658637","article-title":"Screening of compounds for anti-tuberculosis Activity, and in\u00a0vitro and in\u00a0vivo evaluation of potential candidates","volume":"12","author":"Zhou","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmech.2022.114173_bib148","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/978-3-030-32622-7_10","article-title":"Artificial neural networks in computer-aided drug design: an overview of recent advances","volume":"1194","author":"Cheirdaris","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ejmech.2022.114173_bib149","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3390\/md18120633","article-title":"A\u00a0Computer-aided drug design approach to predict marine drug-like leads for sars-cov-2 main protease inhibition","volume":"18","author":"Gaud\u00eancio","year":"2020","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2022.114173_bib150","doi-asserted-by":"crossref","first-page":"6839","DOI":"10.1038\/s41598-020-63913-9","article-title":"Computer-aided synthesis of dapsone-phytochemical conjugates against dapsone-resistant Mycobacterium leprae","volume":"10","author":"Swain","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2022.114173_bib151","first-page":"1","article-title":"Anti-HIV-drug and phyto-flavonoid combination against SARS-CoV-2: a molecular docking-simulation base assessment","author":"Swain","year":"2021","journal-title":"J.\u00a0Biomol. Struct. Dyn."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422000757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422000757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:38:33Z","timestamp":1759329513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523422000757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":150,"alternative-id":["S0223523422000757"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114173","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quinoline heterocyclic containing plant and marine candidates against drug-resistant Mycobacterium tuberculosis: A systematic drug-ability investigation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114173","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114173"}}